Difference between revisions of "Team:MIT"
| Line 16: | Line 16: | ||
<a href="https://2016.igem.org/Team:MIT/Experiments/Promoters"> | <a href="https://2016.igem.org/Team:MIT/Experiments/Promoters"> | ||
<img src="https://static.igem.org/mediawiki/2016/1/16/T--MIT--synpromobutton.svg" alt="Promoters" > | <img src="https://static.igem.org/mediawiki/2016/1/16/T--MIT--synpromobutton.svg" alt="Promoters" > | ||
| − | <span class="text-content"><span | + | <span class="text-content"><span><br><br><br><br><br><br>Read more about how we created synthetic promoters to respond to this disease marker<br><br></span></span> |
</a> | </a> | ||
</li> | </li> | ||
| Line 22: | Line 22: | ||
<a href="https://2016.igem.org/Team:MIT/Experiments/miRNA"> | <a href="https://2016.igem.org/Team:MIT/Experiments/miRNA"> | ||
<img src="https://static.igem.org/mediawiki/2016/8/89/T--MIT--miRNAsensorsbutton.svg" alt="miRNA" > | <img src="https://static.igem.org/mediawiki/2016/8/89/T--MIT--miRNAsensorsbutton.svg" alt="miRNA" > | ||
| − | <span class="text-content"><span | + | <span class="text-content"><span><br><br><br><br><br><br>Read more about how we characterized miRNA profiles in model cells under varying conditions<br><br></span></span> |
</a> | </a> | ||
</li> | </li> | ||
| Line 28: | Line 28: | ||
<a href="https://2016.igem.org/Team:MIT/Experiments/Recombinases"> | <a href="https://2016.igem.org/Team:MIT/Experiments/Recombinases"> | ||
<img src="https://static.igem.org/mediawiki/2016/e/e2/T--MIT--recombinasesbutton.svg" alt="Recombinases" > | <img src="https://static.igem.org/mediawiki/2016/e/e2/T--MIT--recombinasesbutton.svg" alt="Recombinases" > | ||
| − | <span class="text-content"><span | + | <span class="text-content"><span><br><br><br><br><br><br>Read more about how we use recombinases to give the circuit memory across a cycle<br><br></span></span> |
</a> | </a> | ||
</li></ul><br> | </li></ul><br> | ||
Revision as of 02:50, 17 October 2016
This diagnostic process can be expedited with synthetic biological tools that sense the following molecular markers in endometrial biopsy samples.
-
Read more about how we created synthetic promoters to respond to this disease marker
-
Read more about how we characterized miRNA profiles in model cells under varying conditions
-
Read more about how we use recombinases to give the circuit memory across a cycle
